Drug Target Review Q&A with Cellarity
| Section Heading | Section Content |
|---|---|
| Overview |
Cellarity’s CEO Fabrice Chouraqui spoke with Drug Target Review about the advantages of targeting the whole cell rather than a single molecular target in drug discovery. This approach allows us to unravel the complexity of disease biology and discover new drugs, even when there is no known target. |
Up Next